Skip to main content
Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.72
-0.36 (-1.33%)
At close: Mar 5, 2026, 4:00 PM EST
26.50
-0.22 (-0.82%)
Pre-market: Mar 6, 2026, 8:50 AM EST

Immunovant Employees

Immunovant had 362 employees as of March 31, 2025. The number of employees increased by 155 or 74.88% compared to the previous year.

Employees
362
Change (1Y)
155
Growth (1Y)
74.88%
Revenue / Employee
n/a
Profits / Employee
-$1,282,318
Market Cap
5.44B

Employees Chart

Employees History

Date Employees Change Growth
Mar 31, 202536215574.88%
Mar 31, 20242074326.22%
Mar 31, 20231644032.26%
Mar 31, 20221245682.35%
Mar 31, 2021682661.90%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Related Stocks

Company Name Employees
Caris Life Sciences 1,769
PTC Therapeutics 991
Rhythm Pharmaceuticals 414
CRISPR Therapeutics AG 393
Mirum Pharmaceuticals 372
Cogent Biosciences 258
Apogee Therapeutics 196
CG Oncology 142
Employee Rankings

IMVT News

More News